TPL Plastech Ltd reports Q2 & H1 FY27 unaudited results; Q2 PAT ₹83.8 Mn, up 22.3% YoY
TPL Plastech · Industrial Products
Key highlights
- Q2 FY27 revenue from operations ₹1,495.2 Mn (+39.9% YoY), EBITDA ₹138.6 Mn (+16.7%), PAT ₹83.8 Mn (+22.3%)
- H1 FY27 revenue from operations ₹2,740.6 Mn (+38.8%), EBITDA ₹253.3 Mn (+15.6%), PAT ₹150.5 Mn (+22.2%)
- Bhuj facility began commercial operations; expected additional annual revenue ~₹100 Cr in 3 years. Board approved merger into Time Technoplast, subject to approvals and NCLT order
Why it's rated notable: the year-on-year change is 22% (20% to 50%)
Figures checked against the filing by a second AI read, which corrected the first summary. About the business, not the share price.
Original filing
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Electrical Equipment
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from TPL Plastech
- Management changeNotableTPL Plastech Ltd appoints new CEO; approves quarterly financials ending Sept 2026
- Capex / expansionNotableTPL Plastech Board Approves Sept 2026 Quarter Results; CEO Change Announced
- Acquisition / mergerNotableTPL Plastech Limited to merge with Time Technoplast Limited; share exchange ratio approved
- Acquisition / mergerNotableTPL Plastech board approves merger into Time Technoplast; 403 shares per 1,000
- Acquisition / mergerNotableTPL Plastech Limited to hold board meeting on September 29, 2026 for merger approval
Other acquisition / merger filings this fortnight
- Sahasra Electronic Solutions receives NSE No Objection Letter for scheme of amalgamation
- Narayana Hrudayalaya: NCLT sanctions demerger of NH Integrated Care clinics into company
- Websol Energy approves Sept 2026 quarter results and 40% stake in Bright Earth Cell
- Aurobindo Pharma reports unaudited Q2 and half-year results ended September 30, 2026
- Gretex Industries board approves unaudited half-year results to Sept 30, 2026
- Pajson Agro board approves ESOS 2026, share capital rise and Pacific Global acquisition
Potential multibaggers · Q2 FY27
Potential multibaggers in Industrial Products
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.